RSS Feed
Video
The Next Big Thing in Biotech: Pfizer
Senior columnist Adam Feuerstein says Pfizer is the next big thing in biotech.
06:00AM 05/04/12
Video
The Next Big Thing in Biotech: M&A
Senior columnist Adam Feuerstein says M&A is the next big thing in biotech.
05:00AM 04/27/12
Video
The Next Big Thing in Biotech: Alexza
Adam Feuerstein, senior columnist for TheStreet, explains why Alexza Pharmaceuticals is the next big thing in biotech.
06:30AM 04/13/12
Video
The Next Big Thing in Biotech: 2Q Preview
Senior columnist Adam Feuerstein reviews the first quarter's biotech winners and also looks ahead to the second quarter.
05:00AM 03/30/12
Video
The Next Big Thing in Biotech: Vivus, Chelsea
Adam Feuerstein explains why Vivus and Chelsea Therapeutics are the next big things in biotech.
05:00AM 02/17/12
Video
The Next Big Thing in Biotech: Medivation
Adam Feuerstein, senior columnist for TheStreet, explains why Medivation is the next big thing in biotech.
06:30AM 01/27/12
Video
The Next Big Thing in Biotech: Amylin
Senior columnist Adam Feuerstein explains what's important about Amylin Pharmaceuticals.
05:45AM 01/20/12
Video
Next Big Thing in Biotech: Celgene
Adam Feuerstein explains why Celgene will be the biotech stock to watch in the coming week.
05:15AM 01/13/12
Video
The Next Big Thing In Biotech: 2012 Outlook
Adam Feuerstein, senior columnist for TheStreet, previews next week's JP Morgan Healthcare Conference and also looks ahead to 2012.
05:15AM 01/06/12
Video
The Next Big Thing in Biotech: 2011 Review
Adam Feuerstein, senior columnist for TheStreet, reviews the biggest biotech stories in 2011 and also looks ahead to 2012.
07:45AM 12/16/11
Connect with TheStreet